OMEROS CORP Variable Lease, Cost
OMEROS CORP (OMER) reported Variable Lease, Cost of $921.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-12
- OMEROS CORP variable lease, cost for the quarter ending 2026-06-30 was $921.00K, a 3.05% decline year-over-year.
- OMEROS CORP variable lease, cost for the quarter ending 2026-03-31 was $985.00K, a 3.68% increase year-over-year.
- OMEROS CORP variable lease, cost for the quarter ending 2025-12-31 was $904.00K, a 6.48% increase year-over-year.
- OMEROS CORP variable lease, cost for the quarter ending 2025-09-30 was $928.00K, a 12.62% increase year-over-year.
- OMEROS CORP variable lease, cost for fiscal 2025 was $3.72M, a 7.26% increase from fiscal 2024.
- OMEROS CORP variable lease, cost for fiscal 2024 was $3.47M, a 9.84% increase from fiscal 2023.
- OMEROS CORP variable lease, cost for fiscal 2023 was $3.16M, a 0.97% decline from fiscal 2022.
- OMEROS CORP variable lease, cost for fiscal 2022 was $3.19M, a 9.32% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $921.00K 10-Q · filed 2026-08-12 | $1.91M 10-Q · filed 2026-08-12 | $2.81M derived: sum of 3 quarters · filed 2026-08-12 | $3.74M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $985.00K 10-Q · filed 2026-05-13 | $1.89M derived: sum of 2 quarters · filed 2026-05-13 | $2.82M derived: sum of 3 quarters · filed 2026-05-13 | $3.77M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $904.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.83M derived: sum of 2 quarters · filed 2026-03-31 | $2.78M derived: sum of 3 quarters · filed 2026-08-12 | $3.72M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $928.00K 10-Q · filed 2025-11-13 | $1.88M derived: sum of 2 quarters · filed 2026-08-12 | $2.82M 10-Q · filed 2025-11-13 | $3.68M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $950.00K 10-Q · filed 2026-08-12 | $1.89M 10-Q · filed 2026-08-12 | $2.75M derived: sum of 3 quarters · filed 2026-08-12 | $3.57M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $950.00K 10-Q · filed 2026-05-13 | $1.80M derived: sum of 2 quarters · filed 2026-05-13 | $2.62M derived: sum of 3 quarters · filed 2026-05-13 | $3.50M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $849.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.67M derived: sum of 2 quarters · filed 2026-03-31 | $2.56M derived: sum of 3 quarters · filed 2026-03-31 | $3.47M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $824.00K 10-Q · filed 2025-11-13 | $1.71M derived: sum of 2 quarters · filed 2025-11-13 | $2.62M 10-Q · filed 2025-11-13 | $3.43M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $882.00K 10-Q · filed 2025-08-14 | $1.80M 10-Q · filed 2025-08-14 | $2.60M derived: sum of 3 quarters · filed 2025-08-14 | $3.41M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $916.00K 10-Q · filed 2025-05-15 | $1.72M derived: sum of 2 quarters · filed 2025-05-15 | $2.53M derived: sum of 3 quarters · filed 2025-05-15 | $3.29M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $806.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.61M derived: sum of 2 quarters · filed 2025-03-31 | $2.37M derived: sum of 3 quarters · filed 2025-03-31 | $3.16M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $807.00K 10-Q · filed 2024-11-13 | $1.56M derived: sum of 2 quarters · filed 2024-11-13 | $2.35M 10-Q · filed 2024-11-13 | $3.15M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $757.00K 10-Q · filed 2024-08-07 | $1.55M 10-Q · filed 2024-08-07 | $2.34M derived: sum of 3 quarters · filed 2024-08-07 | $3.16M derived: sum of 4 quarters · filed 2024-08-07 | ||
| 2023-03-31 | $790.00K 10-Q · filed 2024-05-15 | $1.59M derived: sum of 2 quarters · filed 2024-05-15 | $2.40M derived: sum of 3 quarters · filed 2024-05-15 | $3.12M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.61M derived: sum of 2 quarters · filed 2024-04-01 | $2.33M derived: sum of 3 quarters · filed 2024-04-01 | $3.19M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $813.00K 10-Q · filed 2023-11-09 | $1.53M derived: sum of 2 quarters · filed 2023-11-09 | $2.40M 10-Q · filed 2023-11-09 | $3.25M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $722.00K 10-Q · filed 2023-08-09 | $1.58M 10-Q · filed 2023-08-09 | $2.43M derived: sum of 3 quarters · filed 2023-08-09 | $3.30M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $860.00K 10-Q · filed 2023-05-09 | $1.71M derived: sum of 2 quarters · filed 2023-05-09 | $2.58M derived: sum of 3 quarters · filed 2023-05-09 | $3.57M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $1.72M derived: sum of 2 quarters · filed 2023-03-13 | $2.71M derived: sum of 3 quarters · filed 2023-03-13 | $3.52M 10-K · filed 2023-03-13 | ||
| 2021-09-30 | $863.00K 10-Q · filed 2022-11-09 | $1.85M derived: sum of 2 quarters · filed 2022-11-09 | $2.67M 10-Q · filed 2022-11-09 | $3.85M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $992.00K 10-Q · filed 2022-08-09 | $1.80M 10-Q · filed 2022-08-09 | $2.98M derived: sum of 3 quarters · filed 2022-08-09 | $3.63M derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | $813.00K 10-Q · filed 2022-05-10 | $1.99M derived: sum of 2 quarters · filed 2022-05-10 | $2.64M derived: sum of 3 quarters · filed 2022-05-10 | $3.20M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.83M derived: sum of 2 quarters · filed 2022-03-01 | $2.39M derived: sum of 3 quarters · filed 2022-03-01 | $2.89M 10-K · filed 2022-03-01 | ||
| 2020-09-30 | $648.00K 10-Q · filed 2021-11-09 | $1.21M derived: sum of 2 quarters · filed 2021-11-09 | $1.72M 10-Q · filed 2021-11-09 | $2.38M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $565.00K 10-Q · filed 2021-08-09 | $1.10M 10-Q · filed 2021-08-09 | $1.73M derived: sum of 3 quarters · filed 2021-08-09 | $2.45M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $542.00K 10-Q · filed 2021-05-10 | $1.16M derived: sum of 2 quarters · filed 2021-05-10 | $1.88M derived: sum of 3 quarters · filed 2021-05-10 | $2.38M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $621.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.34M derived: sum of 2 quarters · filed 2021-03-01 | $1.83M derived: sum of 3 quarters · filed 2021-03-01 | $2.32M 10-K · filed 2021-03-01 | $2.04M 10-K · filed 2020-03-02 | |
| 2019-09-30 | $719.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.21M derived: sum of 2 quarters · filed 2020-11-09 | $1.70M 10-Q · filed 2020-11-09 | $1.42M 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | $494.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $980.00K 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | $486.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |